These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 39186715)

  • 21. Effects of antiviral therapy on long-term outcome after liver resection for hepatitis B virus-related hepatocellular carcinoma.
    Urata Y; Kubo S; Takemura S; Uenishi T; Kodai S; Shinkawa H; Sakae M; Kaneda K; Ohata K; Nozawa A; Suehiro S
    J Hepatobiliary Pancreat Sci; 2012 Nov; 19(6):685-96. PubMed ID: 22203455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High hepatitis B viral load predicts recurrence of small hepatocellular carcinoma after curative resection.
    Qu LS; Jin F; Huang XW; Shen XZ
    J Gastrointest Surg; 2010 Jul; 14(7):1111-20. PubMed ID: 20422305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of nucleoside and nucleotide analogs in the recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection: A multicenter study.
    Qi W; Shen J; Dai J; Wu Y; Zhang Y; Leng S; Gao F; Ran S; Peng W; Zhang X; Wen T; Li C
    Cancer Med; 2021 Dec; 10(23):8421-8431. PubMed ID: 34643050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical effect of antiviral therapy in patients with hepatitis B virus-related decompensated cirrhosis and undetectable DNA.
    Lee HA; Lee YS; Jung YK; Kim JH; Yim HJ; Yeon JE; Seo YS; Lee JS; Lee HW; Kim BK; Park JY; Kim DY; Ahn SH; Kim SU
    J Gastroenterol Hepatol; 2023 May; 38(5):716-723. PubMed ID: 36681856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels: A Randomized Controlled Trial.
    Huang G; Li PP; Lau WY; Pan ZY; Zhao LH; Wang ZG; Wang MC; Zhou WP
    Ann Surg; 2018 Dec; 268(6):943-954. PubMed ID: 29521740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy.
    Hosaka T; Suzuki F; Kobayashi M; Hirakawa M; Kawamura Y; Yatsuji H; Sezaki H; Akuta N; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kobayashi M; Kumada H
    Liver Int; 2010 Nov; 30(10):1461-70. PubMed ID: 20840396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between nucleoside analogues and risk of hepatitis B virus–related hepatocellular carcinoma recurrence following liver resection.
    Wu CY; Chen YJ; Ho HJ; Hsu YC; Kuo KN; Wu MS; Lin JT
    JAMA; 2012 Nov; 308(18):1906-14. PubMed ID: 23162861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High HBV-DNA titer in surrounding liver rather than in hepatocellular carcinoma tissue predisposes to recurrence after curative surgical resection.
    Choi JG; Chung YH; Kim JA; Jin YJ; Park WH; Lee D; Shim JH; Lee YS; Seo DD; Jang MK; Kim KM; Lim YS; Lee HC; Lee YS; Yu E; Lee YJ
    J Clin Gastroenterol; 2012; 46(5):413-9. PubMed ID: 22105184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load.
    Sohn W; Paik YH; Cho JY; Ahn JM; Choi GS; Kim JM; Kwon CH; Joh JW; Sinn DH; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Viral Hepat; 2015 Jun; 22(6):539-50. PubMed ID: 25377516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBV is a risk factor for poor patient prognosis after curative resection of hepatocellular carcinoma: A retrospective case-control study.
    Li Z; Zhao X; Jiang P; Xiao S; Wu G; Chen K; Zhang X; Liu H; Han X; Wang S; Li X
    Medicine (Baltimore); 2016 Aug; 95(31):e4224. PubMed ID: 27495026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
    Yoo S; Kim JY; Lim YS; Han S; Choi J
    J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus.
    Lee JI; Kim JK; Chang HY; Lee JW; Kim JM; Chung HJ; Kim YS; Lee KS
    J Gastroenterol Hepatol; 2014 May; 29(5):1019-27. PubMed ID: 24325315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver transplantation for hepatitis B virus: Decreasing indication and changing trends.
    Al-Hamoudi W; Elsiesy H; Bendahmash A; Al-Masri N; Ali S; Allam N; Al Sofayan M; Al Bahili H; Al Sebayel M; Broering D; Saab S; Abaalkhail F
    World J Gastroenterol; 2015 Jul; 21(26):8140-7. PubMed ID: 26185387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study.
    Huang CH; Wu VC; Wang CL; Wu CL; Huang YT; Chang SH
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
    Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
    Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High serum hyaluronic acid and HBV viral load are main prognostic factors of local recurrence after complete radiofrequency ablation of hepatitis B-related small hepatocellular carcinoma.
    Xia F; Lai EC; Lau WY; Ma K; Li X; Bie P; Qian C
    Ann Surg Oncol; 2012 Apr; 19(4):1284-91. PubMed ID: 21913016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
    Chong CC; Wong GL; Lai PB
    World J Gastroenterol; 2014 May; 20(20):6006-12. PubMed ID: 24876723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Outcomes of Hepatitis B Virus-Related Hepatocellular Carcinoma Patients with Undetectable Serum HBV DNA Levels.
    Chang JI; Sinn DH; Cho H; Kim S; Kang W; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW
    Dig Dis Sci; 2022 Sep; 67(9):4565-4573. PubMed ID: 34800218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.
    Choi J; Jo C; Lim YS
    Hepatology; 2021 Feb; 73(2):661-673. PubMed ID: 32324905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-dose hepatitis B immunoglobulin therapy in hepatocellular carcinoma with hepatitis B virus-DNA/hepatitis B e antigen-positive patients after living donor liver transplantation.
    Lee EC; Kim SH; Lee SD; Park H; Lee SA; Park SJ
    World J Gastroenterol; 2016 Apr; 22(14):3803-12. PubMed ID: 27076765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.